Related Experiment Videos
Lung transplantation in children
1University of Pennsylvania School of Medicine, USA.
Insights
Pediatric lung transplantation improves survival for children with end-stage cardiopulmonary disease. Early evaluation and specialized care are crucial, especially for those with pulmonary hypertension, to optimize outcomes in pediatric lung recipients.
Area of Science:
- Pediatric Pulmonology
- Cardiothoracic Surgery
- Transplantation Medicine
Background:
- Lung transplantation offers significant survival and quality of life benefits for pediatric patients with end-stage cardiopulmonary disease.
- Children with pulmonary hypertension are often referred late for lung transplantation, leading to high mortality before organ availability.
- Existing transplantation protocols may not be suitable for pediatric populations due to developmental differences.
Purpose of the Study:
- To highlight the importance of timely referral and specialized care for pediatric lung transplant candidates.
- To emphasize the need for tailored protocols considering developmental variations in pediatric lung transplantation.
- To advocate for an integrated research approach combining clinical observation and bench research for improved pediatric lung transplant outcomes.
Main Methods:
- Review of clinical experience with pediatric lung transplantation.
- Analysis of outcomes for children with end-stage cardiopulmonary disease, including those with pulmonary hypertension.
- Consideration of developmental differences in the physiological response to lung transplantation in children.
Main Results:
- Late referral for lung transplantation in children with pulmonary hypertension contributes to pre-transplant mortality.
- Standard transplantation protocols may require modification for pediatric patients.
- An integrated approach combining clinical data and basic research is essential for advancing pediatric lung transplantation.
Conclusions:
- Optimizing lung transplantation outcomes in children requires accurate disease staging via cardiac catheterization and timely listing.
- Referral to experienced pediatric centers is critical for managing end-stage cardiovascular disease and improving survival.
- Further research is needed to understand and address developmental differences in pediatric lung transplantation.
Abstract:
Lung transplantation can offer improved quality of life and prolonged survival to children who have end-stage cardiopulmonary disease, even in the presence of characteristics that have been considered poor prognostic indicators. At present, children who have pulmonary hypertension tend to be referred for transplantation late in the course of their disease; as a result, almost half die before organs become available. Cardiac catheterization for accurate disease staging, appropriate timing of evaluation and listing for transplantation, and referral to centers experienced in the treatment of children who have end-stage cardiovascular disease are all essential components of a process that will improve survival in such children. Our experience indicates that there may be important developmental differences in the body's response to lung transplantation; thus, protocols that are suitable for older adolescents and adults may be unsuitable for young children. An integrative approach to investigation of these issues, i.e., one in which careful clinical observation and data acquisition are combined with targeted bench research, is most likely to result in insights that will directly benefit patients.